Vor Biopharma Inc. (VOR) Financials
VOR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 198.1 million | 47.4 million |
2023-09-30 | 223.0 million | 48.2 million |
2023-06-30 | 251.0 million | 46.5 million |
2023-03-31 | 277.5 million | 47.3 million |
VOR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -24.1 million | 1.9 million |
2023-09-30 | -28.4 million | 3.2 million |
2023-06-30 | -24.5 million | 4.2 million |
2023-03-31 | -24.4 million | 4.1 million |
VOR Net Income
No data available :(
VOR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 35.7 million |
2023-09-30 | 160.1 million | - | 36.6 million |
2023-06-30 | 186.9 million | - | 37.5 million |
2023-03-31 | 210.2 million | - | 38.5 million |
VOR Shares Outstanding
VOR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 111000 | 20.9 million | 7.2 million | - |
2023-09-30 | 465000 | 27.6 million | 7.7 million | - |
2023-06-30 | 399000 | 23.9 million | 8.3 million | - |
2023-03-31 | 94000 | 21.9 million | 8.5 million | - |
VOR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | - | 2.1 million |
2023-06-30 | - | 1.2 million |
2023-03-31 | - | 2.8 million |
VOR
Price: $1.69
52 week price:
Earnings Per Share: -1.75 USD
P/E Ratio: -1.17
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 63919
Market Capitalization: 129.6 million